Αποτελέσματα Αναζήτησης
30 Αυγ 2024 · ESC Clinical Practice Guidelines aim to present all the relevant evidence to help physicians weigh the benefits and risks of a particular diagnostic or therapeutic procedure on Atrial Fibrillation. They should be essential in everyday clinical decision making.
30 Νοε 2023 · In addition, new recommendations addressing atrial fibrillation and thromboembolic risk assessment, anticoagulation, left atrial appendage occlusion, atrial fibrillation catheter or surgical ablation, and risk factor modification and atrial fibrillation prevention have been developed.
The 3 selected messages are focused on the new stages of atrial fibrillation (take-home message 1), the importance of early rhythm control (take-home message 5), and the use of catheter ablation as first-line therapy in select patients (take-home message 6).
AIM: The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation” provides recommendations to guide clinicians in the treatment of patients with atrial fibrillation. METHODS : A comprehensive literature search was conducted from May 12, 2022, to November 3, 2022, encompassing
30 Αυγ 2024 · Tables 3 and 4 below outline new recommendations and those with important revisions. These initiatives have been designed to make the 2024 ESC Guidelines for the management of AF easier to read, follow, and implement, with the aim of improving the lives of patients with AF.
The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Patients With Atrial Fibrillation” provides recommendations to guide clinicians in the treatment of patients with atrial fibrillation.
29 Αυγ 2018 · The American College of Chest Physicians (ACCP) has updated their 2012 guidelines on the use of antithrombotic medications for patients with atrial fibrillation (AF). They recommend the use of the CHA 2 DS 2 -VASc score in AF patients to estimate the risk of ischemic stroke and systemic embolism.
